Vanguard Group’s Salarius Pharmaceuticals SLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $7.7K | Hold |
|
|||||
|
2023
Q4 | $9.47K | Buy |
|
|||||
|
2023
Q3 | $9.38K | Sell |
|
|||||
|
2023
Q2 | $22.3K | Sell |
|
|||||
|
2023
Q1 | $29.5K | Sell |
|
|||||
|
2022
Q4 | $58.4K | Sell |
|
|||||
|
2022
Q3 | $264K | Sell |
|
|||||
|
2022
Q2 | $333K | Hold |
|
|||||
|
2022
Q1 | $631K | Hold |
|
|||||
|
2021
Q4 | $785K | Hold |
|
|||||
|
2021
Q3 | $1.62M | Buy |
|
|||||
|
2021
Q2 | $1.64M | Buy |
|
|||||
|
2021
Q1 | $2.1M | Buy |
|
|||||
|
2020
Q4 | $88K | Buy |
|
|||||
|
2020
Q3 | $32K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $66K | Hold |
|
|||||
|
2019
Q1 | $46K | Hold |
|
|||||
|
2018
Q4 | $39K | Sell |
|
|||||
|
2018
Q3 | $106K | Sell |
|
|||||
|
2018
Q2 | $321K | Buy |
|
|||||
|
2018
Q1 | $1.66M | Hold |
|
|||||
|
2017
Q4 | $1.07M | Hold |
|
|||||
|
2017
Q3 | $925K | Hold |
|
|||||
|
2017
Q2 | $1.02M | Hold |
|
|||||
|
2017
Q1 | $1.4M | Hold |
|
|||||
|
2016
Q4 | $1.65M | Sell |
|
|||||
|
2016
Q3 | $4.08M | Hold |
|
|||||
|
2016
Q2 | $3.51M | Buy |
|
|||||
|
2016
Q1 | $3.34M | Buy |
|
|||||
|
2015
Q4 | $2.8M | Buy |
|
|||||
|
2015
Q3 | $2.13M | Hold |
|
|||||
|
2015
Q2 | $2.77M | Hold |
|
|||||
|
2015
Q1 | $2.97M | Buy |
|